| XLS |
|
Merck Group | Key figures | ||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ million |
Q2 2012 |
Q2 2011 |
Change |
Jan.–June |
Jan.–June |
Change |
|
Total revenues |
2,852.1 |
2,555.4 |
11.6% |
5,497.1 |
5,119.1 |
7.4% |
|
Sales |
2,743.1 |
2,469.6 |
11.1% |
5,307.0 |
4,947.1 |
7.3% |
|
Operating result (EBIT) |
23.2 |
–23.7 |
n.m. |
333.8 |
504.6 |
–33.9% |
|
Margin (% of sales) |
0.8% |
–1.0% |
|
6.3% |
10.2% |
|
|
EBITDA |
375.0 |
563.3 |
–33.4% |
1,028.3 |
1,444.5 |
–28.8% |
|
Margin (% of sales) |
13.7% |
22.8% |
|
19.4% |
29.2% |
|
|
EBITDA pre one-time items |
746.6 |
655.2 |
13.9% |
1,420.9 |
1,390.7 |
2.2% |
|
Margin (% of sales) |
27.2% |
26.5% |
|
26.8% |
28.1% |
|
|
EPS pre one-time items (€) |
1.92 |
1.60 |
20.0% |
3.58 |
3.50 |
2.3% |
|
Free cash flow |
625.7 |
253.2 |
147.1% |
1,045.4 |
898.5 |
16.3% |
